Statin versus no statin after treatment with pipeline embolization device for intracranial aneurysms: a meta-analysis
Arquivos de Neuro-Psiquiatria · 01.06.2025 · 83 (06) · 001-008
DOI: 10.1055/s-0045-1809545 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Arquivos de Neuro-Psiquiatria, erschienen am 01.06.2025. Verfasst von Nathalia Soares Barbosa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória, Vitória ES, Brazil. Hauptthemen laut MEDLINE: Intracranial Aneurysm, Embolization, Therapeutic, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Some studies demonstrated the role of statin therapy in improving outcomes after coil embolization or surgical clipping of cerebral aneurysm. However, the benefit of statins after pipeline embolization device (PED) for intracranial aneurysms is not well established. To evaluate the effects of statins on hemorrhagic and ischemic complications as well as on complete occlusion of aneurysm in the treatment with PED. We searched the PubMed, Embase, and Cochrane Library databases for articles published from their inception to November 2024. Data were collected from observational studies comparing statin to no statin therapy following pipeline embolization. Four studies were included, comprising 2,822 patients and 3,063 aneurysms, 127 of which were ruptured and 4 of which received adjunctive coil embolization. Total hemorrhagic complication was reduced in the statin group (risk ratio [RR] = 0.50; 95%CI: 0.29–0.85; p = 0.010; I2 = 0%) but did not reveal difference in restricted propensity score-matched (PSM) analysis (RR= 0.50; 95%CI: 0.24–1.07 p = 0.073; I2 = 27%). There was no difference between the groups in complete occlusion of aneurysm rate at the last follow-up (RR = 0.94; 95%CI: 0.88–1.00; p = 0.055; I2 = 8.0%) or total ischemic complications (RR = 1.48; 95%CI: 1.06–2.07; p = 0.021; I2 = 0%). Statin use significantly reduced hemorrhagic complications after PED; however, this result should be interpreted cautiously due to study limitations. No significant differences were noted in complete occlusion rates or ischemic complications between the groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória, Vitória ES, Brazil.
- Universidade Federal de Uberlândia, Uberlândia MG, Brazil.
- Jubilee Mission Medical College and Research Institute, Thrissur Kerala, India.
- Universidade Estadual Paulista, Botucatu SP, Brazil.
- Universidade de São Paulo, Departamento de Neurologia, São Paulo SP, Brazil.
- Hospital Estadual Central, Departamento de Neurocirurgia, Vitória ES, Brazil.
ORCID-Profile: Nathalia Soares Barbosa, Felipe Araujo Gouhie, Bezalel Hakkeem, Amanda Machado, João Paulo Mota Telles, Luís Gustavo Biondi Soares, Leandro de Assis Barbosa
Zitieren
APA
Barbosa, N. S., Gouhie, F. A., Hakkeem, B., Machado, A., Telles, J. P. M., Soares, L. G. B., & Barbosa, L. A. (2025). Statin versus no statin after treatment with pipeline embolization device for intracranial aneurysms: a meta-analysis. Arquivos de Neuro-Psiquiatria, 83(06), 001-008. https://doi.org/10.1055/s-0045-1809545
Vancouver
Barbosa NS, Gouhie FA, Hakkeem B, Machado A, Telles JPM, Soares LGB, et al. Statin versus no statin after treatment with pipeline embolization device for intracranial aneurysms: a meta-analysis. Arquivos de Neuro-Psiquiatria. 2025;83(06):001-008. doi:10.1055/s-0045-1809545
BibTeX
@article{Barbosa2025,
author = {Barbosa, Nathalia Soares and Gouhie, Felipe Araujo and Hakkeem, Bezalel and Machado, Amanda and Telles, João Paulo Mota and Soares, Luís Gustavo Biondi and Barbosa, Leandro de Assis},
title = {Statin versus no statin after treatment with pipeline embolization device for intracranial aneurysms: a meta-analysis},
journal = {Arquivos de Neuro-Psiquiatria},
year = {2025},
volume = {83},
number = {06},
pages = {001--008},
doi = {10.1055/s-0045-1809545}
}
EUVIMED